Autopsy report · NCT01726569

Post-operative Satisfaction With Glaucoma Surgery Trial

“study sites were reconsidered.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Sun Yat-sen University

Sponsor type

University, hospital or other

Conditions

Glaucoma

Interventions

film and trained counseling; traditional counseling

Participants

0

Sites

1

Countries

China

Trials that died the same way

• Estimate Serum Oxytocin PD Range in the Periphery
  “Study will be replaced by a revised study protocol” (65% match in meaning)
• A Trial Measuring ART-123 Ability to Prevent Sensory Neuropathy in Unresectable mCRC Subjects w/Oxaliplatin-based Chemo
  “Study design was changed” (62% match in meaning)
• Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced Leukemia
  “Replaced with another study” (62% match in meaning)
• Impact of Neutrophil Extracellular Traps on Tissue Plasminogen Activator Induced Thrombolysis in Acute Ischemic Stroke Patients
  “replaced by a new study” (62% match in meaning)
• Gene Expression During Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Choline Magnesium Trisalicylate
  “Replaced by another study” (62% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.